ANNOUNCEMENT 19 Dec 2008

In December 2008, the government of France announced a change in the access to public tenders.

NUMBER OF INTERVENTIONS

1

  • 0 harmful
  • 1 neutral
  • 0 liberalising
Inception date: 19 Dec 2008 | Removal date: open ended
Still in force

Public procurement access

According to the Décret no 2008-1355, issued on 19 December 2008, relating to the implementation of the French stimulus plan, with respect to public procurement, the maximum threshold for the value of a construction project where an awarding authority can follow a loose public procurement procedure ('procédure adaptée') was increased from EUR 206'000 plus state sales tax to EUR 5'150'000 plus state sales tax. The EUR 5'150'000 plus state sales tax limit corresponds to the maximum threshold allowed by the EU. 
The modalities of a 'procédure adaptée' can be freely fixed by the awarding authority. The modalities to be chosen include: the nature and features of the specifications required, the number and origins of the potential economic operators that can respond to the authority, and the circumstances of the purchase.
Moreover, Décret no 2008-1355 allows the awarding authority to negotiate - mainly with respect to prices - with those bidders that present an offer. 
Finally, the awarding authority can decide that the project does not go through a open tendering procedure if the circumstances justify it or the maximum expected value of the project is below EUR 20'000 plus state sales tax. This amount was increased in Décret no 2008-1355 from previously EUR 4'000 plus state sales tax.
Investigating the official French public procurement database 'Bulletin officiel des annonces des marchés publics', it can be viewed that 118 out of 197 new construction tenders in 2009 follow the 'procédure adaptée'.
Although these amendments are likely to comply with EU law, the higher thresholds allow more French stimulus spending to fall outside EU procurement rules designed to open up public contracts to international competition.

AFFECTED SECTORS

 

AFFECTED PRODUCTS

 
N/A